282 related articles for article (PubMed ID: 33562801)
1. Challenges and Opportunities in NUT Carcinoma Research.
Hakun MC; Gu B
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562801
[TBL] [Abstract][Full Text] [Related]
2. CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies.
Schaefer IM; Dal Cin P; Landry LM; Fletcher CDM; Hanna GJ; French CA
Genes Chromosomes Cancer; 2018 Sep; 57(9):446-451. PubMed ID: 29700887
[TBL] [Abstract][Full Text] [Related]
3. A recurrent novel
Diolaiti D; Dela Cruz FS; Gundem G; Bouvier N; Boulad M; Zhang Y; Chou AJ; Dunkel IJ; Sanghvi R; Shah M; Geiger H; Rahman S; Felice V; Wrzeszczynski KO; Darnell RB; Antonescu CR; French CA; Papaemmanuil E; Kung AL; Shukla N
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30552129
[No Abstract] [Full Text] [Related]
4. Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family.
Chien YW; Hsieh TH; Chu PY; Hsieh SM; Liu ML; Lee JC; Liu YR; Ku JW; Kao YC
Genes Chromosomes Cancer; 2019 Nov; 58(11):809-814. PubMed ID: 31334571
[TBL] [Abstract][Full Text] [Related]
5. NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion.
Chen M; Zhao S; Liang Z; Wang W; Zhou P; Jiang L
Virchows Arch; 2022 Apr; 480(4):887-897. PubMed ID: 35064291
[TBL] [Abstract][Full Text] [Related]
6. NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas.
Agaimy A; Fonseca I; Martins C; Thway K; Barrette R; Harrington KJ; Hartmann A; French CA; Fisher C
Am J Surg Pathol; 2018 Jul; 42(7):877-884. PubMed ID: 29649019
[TBL] [Abstract][Full Text] [Related]
7. "Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism.
Shiota H; Elya JE; Alekseyenko AA; Chou PM; Gorman SA; Barbash O; Becht K; Danga K; Kuroda MI; Nardi V; French CA
Mol Cancer Res; 2018 Dec; 16(12):1826-1833. PubMed ID: 30139738
[TBL] [Abstract][Full Text] [Related]
8. An Overview of Molecular Mechanism, Clinicopathological Factors, and Treatment in NUT Carcinoma.
Huang QW; He LJ; Zheng S; Liu T; Peng BN
Biomed Res Int; 2019; 2019():1018439. PubMed ID: 31815119
[TBL] [Abstract][Full Text] [Related]
9. Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion.
Agaimy A; Haller F; Renner A; Niedermeyer J; Hartmann A; French CA
Am J Surg Pathol; 2022 Feb; 46(2):281-288. PubMed ID: 34232599
[TBL] [Abstract][Full Text] [Related]
10.
Luo W; Stevens TM; Stafford P; Miettinen M; Gatalica Z; Vranic S
Curr Oncol; 2021 Nov; 28(6):4485-4503. PubMed ID: 34898574
[TBL] [Abstract][Full Text] [Related]
11. NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.
French CA
Pathol Int; 2018 Nov; 68(11):583-595. PubMed ID: 30362654
[TBL] [Abstract][Full Text] [Related]
12. Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.
Allison DB; Rueckert J; Cornea V; Lee CY; Dueber J; Bocklage T
Endocr Pathol; 2022 Jun; 33(2):315-326. PubMed ID: 34997561
[TBL] [Abstract][Full Text] [Related]
13. NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum.
Stevens TM; Morlote D; Xiu J; Swensen J; Brandwein-Weber M; Miettinen MM; Gatalica Z; Bridge JA
Mod Pathol; 2019 Jun; 32(6):764-773. PubMed ID: 30723300
[TBL] [Abstract][Full Text] [Related]
14. NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion.
Abreu RF; Oliveira TB; Hertzler H; Toledo RN; D'Almeida Costa F; Lopes Pinto CA; Nunes WA; Nascimento AF; French CA; Nascimento AG
Hum Pathol; 2022 Aug; 126():87-99. PubMed ID: 35623465
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.
Chen M; Chen X; Zhang Y; Wang W; Jiang L
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6361-6370. PubMed ID: 36752907
[TBL] [Abstract][Full Text] [Related]
16. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.
Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH
Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391
[TBL] [Abstract][Full Text] [Related]
17. Supercharging BRD4 with NUT in carcinoma.
Eagen KP; French CA
Oncogene; 2021 Feb; 40(8):1396-1408. PubMed ID: 33452461
[TBL] [Abstract][Full Text] [Related]
18. NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors.
Dickson BC; Sung YS; Rosenblum MK; Reuter VE; Harb M; Wunder JS; Swanson D; Antonescu CR
Am J Surg Pathol; 2018 May; 42(5):636-645. PubMed ID: 29356724
[TBL] [Abstract][Full Text] [Related]
19. NUT Midline Carcinoma of the Lung in a Six-Year-Old Child.
Karakuş E; Poyraz A; Oğuz Erdogan AS; Emir S; Özyörük D
Fetal Pediatr Pathol; 2017 Dec; 36(6):472-474. PubMed ID: 29220605
[TBL] [Abstract][Full Text] [Related]
20. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
French CA; Miyoshi I; Kubonishi I; Grier HE; Perez-Atayde AR; Fletcher JA
Cancer Res; 2003 Jan; 63(2):304-7. PubMed ID: 12543779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
